pharmaphorum

NOVEMBER 28, 2021

An investigator-led trial of Jazz Pharma’s cannabis extract-based drug Sativex in glioblastoma – an aggressive form of brain cancer – will get underway in the UK next year. The three-year phase 2 trial will be carried out by researchers at Leeds University led by professor of clinical oncology and neuro-oncology Susan Short, and see if adding Sativex (nabiximols) to standard chemotherapy for recurrent glioblastoma can extend survival.

Trials 136

Trials Drugs Licensing Containment 136

NY Times

NOVEMBER 28, 2021

A “Frankenstein mix” of mutations raises concerns, but the variant may remain vulnerable to current vaccines. If not, revisions will be necessary.

Vaccination 110

Vaccination Vaccine Scientist Drugs 110

pharmaphorum

NOVEMBER 28, 2021

With governments around the world announcing measures to curb the new B.1.1.529 variant of COVID-19 – now christened Omicron – leading vaccine manufacturers have said they are poised to develop new shots if needed. News of the new variant emerged last week, and has resulted in travel bans being imposed on various African countries by the US, EU and UK, among others.

Vaccination 111

Vaccination Vaccine Protein Immune Response 111

Scienmag

NOVEMBER 28, 2021

During the first 9 months of the COVID-19 pandemic, researchers did not find a significant difference in the number of new cancer diagnoses in Canadian children compared with before the pandemic, according to a study published in CMAJ (Canadian Medical Association Journal) [link] “Our findings suggest that among children in Canada, cancer diagnosis was not […].

Research 82

Research 82

Advertisement

Clinical Supply

BioSpace

NOVEMBER 28, 2021

Quell Therapeutics scooped up $156 million in a Series B round this week. The company utilizes regulatory T cells to treat a variety of autoimmune and inflammatory diseases.

76

76

Scienmag

NOVEMBER 28, 2021

At first glance, Antarctica seems inhospitable. Known for howling gales and extremely cold temperatures, the continent is blanketed with a mile-thick ice shelf. Occasional elephant seals and seabirds fleck the glacial shorelines. Credit: Photo by Jordan Scharping At first glance, Antarctica seems inhospitable. Known for howling gales and extremely cold temperatures, the continent is blanketed […].

Research 80

Research 80

Scienmag

NOVEMBER 28, 2021

If you had a jar of marbles of many different colors but wanted only the green ones, how could you efficiently pick them out? What if it wasn’t marbles but a jar of glitter, and there was sand, glue, and mud mixed in? That begins to describe the complexity of the brine pumped out from […].

Engineer 79

Engineer 79

BioSpace

NOVEMBER 28, 2021

?The latest data from Merck and Ridgeback Biotherapeutics' MOVe-OUT trial on the use of molnupiravir to treat COVID-19 in adults has shown a lower efficacy than previously reported.

Trials 68

Trials 68

Drug Patent Watch

NOVEMBER 28, 2021

Annual Drug Patent Expirations for NAVSTEL Navstel is a drug marketed by Alcon Pharms Ltd and is included in one NDA. There is one patent protecting this drug. This drug…. The post New patent expiration for Alcon Pharms drug NAVSTEL appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs Marketing 52

BioSpace

NOVEMBER 28, 2021

Treatment for non-alcoholic steatohepatitis (NASH), a severe form of fatty liver disease, consists mainly of lifestyle modification – specifically dieting and weight loss.

63

63

Advertisement

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

Clinical Trials

BioTech 365

NOVEMBER 28, 2021

QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS QIAGEN and DiaSorin widen access to latent TB testing in the U.S.

FDA Approval 40

FDA Approval 40

BioSpace

NOVEMBER 28, 2021

The deal adds LNG-451, a highly selective brain-penetrant precision therapy targeting EGFR exon 20 insertion mutations, to its pipeline.

73

73

BioTech 365

NOVEMBER 28, 2021

Philips spotlights new and enhanced vendor-neutral radiology workflow solutions and scalable smart connected imaging systems at RSNA 2021 Philips spotlights new and enhanced vendor-neutral radiology workflow solutions and scalable smart connected imaging systems at RSNA 2021 November 28, 2021 Robust … Continue reading →

Radiology 40

Radiology 40

BioSpace

NOVEMBER 28, 2021

Thanksgiving week was marked by numerous clinical trial announcements. Here’s a look.

Clinical Trials 80

Clinical Trials Clinical Trials Trials 80

Advertisement

Clinical Supply

Drug Patent Watch

NOVEMBER 28, 2021

This chart shows the pharmaceutical companies with the most patents in Canada. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Canada? appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52

Drugs 52

FDA Law Blog

NOVEMBER 28, 2021

By Allyson B. Mullen & Jeffrey N. Gibbs & Gail H. Javitt — On November 15, HHS announced that it was withdrawing the prior administration’s policy that prevented FDA from requiring premarket review of laboratory developed tests (LDTs) without notice and comment rule making. See the prior post on this policy here. This statement comes at least six months after the policy was removed from the HHS website without any public notice (a copy of the prior policy is available here for referenc

Regulation 52

Regulation Marketing In-Vitro Development 52